1. Home
  2. AVTX vs GDO Comparison

AVTX vs GDO Comparison

Compare AVTX & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • GDO
  • Stock Information
  • Founded
  • AVTX 2011
  • GDO 2009
  • Country
  • AVTX United States
  • GDO United States
  • Employees
  • AVTX N/A
  • GDO N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • GDO Finance Companies
  • Sector
  • AVTX Health Care
  • GDO Finance
  • Exchange
  • AVTX Nasdaq
  • GDO Nasdaq
  • Market Cap
  • AVTX 88.4M
  • GDO 86.2M
  • IPO Year
  • AVTX 2015
  • GDO N/A
  • Fundamental
  • Price
  • AVTX $7.35
  • GDO $11.47
  • Analyst Decision
  • AVTX Strong Buy
  • GDO
  • Analyst Count
  • AVTX 4
  • GDO 0
  • Target Price
  • AVTX $33.00
  • GDO N/A
  • AVG Volume (30 Days)
  • AVTX 54.4K
  • GDO 39.4K
  • Earning Date
  • AVTX 03-28-2025
  • GDO 01-01-0001
  • Dividend Yield
  • AVTX N/A
  • GDO 9.81%
  • EPS Growth
  • AVTX N/A
  • GDO N/A
  • EPS
  • AVTX N/A
  • GDO N/A
  • Revenue
  • AVTX $820,000.00
  • GDO N/A
  • Revenue This Year
  • AVTX N/A
  • GDO N/A
  • Revenue Next Year
  • AVTX N/A
  • GDO N/A
  • P/E Ratio
  • AVTX N/A
  • GDO N/A
  • Revenue Growth
  • AVTX N/A
  • GDO N/A
  • 52 Week Low
  • AVTX $4.18
  • GDO $11.21
  • 52 Week High
  • AVTX $34.46
  • GDO $13.04
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 42.79
  • GDO 61.08
  • Support Level
  • AVTX $7.42
  • GDO $11.33
  • Resistance Level
  • AVTX $8.50
  • GDO $11.49
  • Average True Range (ATR)
  • AVTX 0.64
  • GDO 0.08
  • MACD
  • AVTX 0.02
  • GDO 0.02
  • Stochastic Oscillator
  • AVTX 17.16
  • GDO 90.00

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.

Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.

Share on Social Networks: